SMAD3 and hepatocellular carcinoma: Additionally, PRMT1 is found to promote EMT through the TGF‐β1/Smad pathway in hepatic carcinoma cells [49], and is required for TGF‐β‐induced Smad3 activation, as well as promoting TGF‐β‐induced EMT [50].